558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study

Sumanta Pal; Ben Tran; John Haanen; Michael Hurwitz; Adrian Sacher; Neeraj Agarwal; Nizar Tannir; Elizabeth Budde; Simon Harrison; Sebastian Klobuch; Sagar Patel; Mary Lee Dequeant; Verena Karsten; Kaitlyn Cohen; Ellen Gurary; Henia Dar; Anna Ma; Anjali Sharma; Samer Srour

doi:10.1136/jitc-2022-SITC2022.0558

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Regular and Young Investigator Award Abstracts

Clinical Trials Completed

558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study

Free

	Abstract	Pdf
Nov 2022	945	61
Dec 2022	242	16
Jan 2023	206	14
Feb 2023	126	20
Total	1519	111

Main menu

Online download statistics by month:

Online download statistics by month: November 2022 to February 2023

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: November 2022 to February 2023

Read the full text or download the PDF:

Log in using your username and password